| Autor: |
Sertaç Ketenci̇, Ender Salbaş, Mustafa Canbaz, Faruk Özşahi̇n |
| Jazyk: |
English<br />Turkish |
| Rok vydání: |
2020 |
| Předmět: |
|
| Zdroj: |
Acta Medica Alanya, Vol 4, Iss 3, Pp 291-295 (2020) |
| Druh dokumentu: |
article |
| ISSN: |
2587-0319 |
| DOI: |
10.30565/medalanya.714362 |
| Popis: |
Infection, primary lung pathology, rheumatic involvement, malignancy and drug-induced involvement can be suggested as differential diagnosis of a case with rheumatic disease who applied to an emergency service with pulmonary symptoms.The drugs cause 2.5-3% of interstitial lung diseases.Sulfasalazine has been widely used in the treatment of inflammatory rheumatic conditions and it is an extremely rare reason for interstitial lung disase. Here, we aimed to present the rarely seen sulfasalazine-induced interstitial pulmonary disease and its treatment. Sulphasalazine -induced lung disease can mimic the symptoms of infectious and rheumatic lung involvement and can cause serious diagnostic confusion. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
